Summit Securities Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.3K | Buy |
+98
| New | +$25.3K | ﹤0.01% | 546 |
|
|
2024
Q3 | – | Sell |
-942
| Closed | -$180K | – | 701 |
|
|
2024
Q2 | $180K | Buy |
+942
| New | +$180K | 0.03% | 92 |
|
|
2024
Q1 | – | Sell |
-1
| Closed | – | – | 647 |
|
|
2023
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 667 |
|
|
2023
Q3 | – | Sell |
-193
| Closed | -$42K | – | 778 |
|
|
2023
Q2 | $42K | Sell |
193
-98
| -34% | -$21.3K | 0.01% | 331 |
|
|
2023
Q1 | $64K | Sell |
291
-1,301
| -82% | -$286K | 0.01% | 255 |
|
|
2022
Q4 | $331K | Buy |
+1,592
| New | +$331K | 0.01% | 178 |
|
|
2022
Q3 | – | Sell |
-303
| Closed | -$64K | – | 897 |
|
|
2022
Q2 | $64K | Buy |
303
+243
| +405% | +$51.3K | 0.01% | 330 |
|
|
2022
Q1 | $15K | Buy |
+60
| New | +$15K | ﹤0.01% | 529 |
|